Balance Sheet Data

Alpine Immune Sciences, Inc. (ALPN)

$10.53

+0.29 (+2.83%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 52.3040.52105.58162.30237.642,160.456,279.7418,253.2753,056.58154,219.03
Total Cash (%)
Account Receivables 0.240.690.3925.320.3932.6094.76275.42800.572,327.02
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.721.540.583.354.2964.12186.37541.721,574.604,576.88
Accounts Payable (%)
Capital Expenditure -0.50-0.82-0.80-0.12-0.41-22.35-64.96-188.80-548.80-1,595.18
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.